Superparamagnetic iron oxide-enhanced magnetic resonance imaging for focal hepatic lesions: Systematic review and meta-analysis

World Journal of Gastroenterology

Volumn 21, Issue 14, 2015, Pages 4334-4344

  Li, You Wei ^a   Chen, Zheng Guang ^b   Wang, Ji Chen ^c   Zhang, Zong Ming ^d  

^a TSINGHUA UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c THE AFFILIATED BENQ HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinomas; Magnetic resonance imaging; Meta analysis; Other lesions; USPIO

Indexed keywords

ANALYSIS; ARTICLE; CANCER DIAGNOSIS; DIAGNOSTIC TEST ACCURACY STUDY; FOCAL HEPATIC LESION; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER INJURY; LIVER RESECTION; META ANALYSIS; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY; SUPERPARAMAGNETIC IRON OXIDE ENHANCED MAGNETIC RESONANCE IMAGING; SYSTEMATIC REVIEW; TASK PERFORMANCE; AREA UNDER THE CURVE; CELL DIFFERENTIATION; CHI SQUARE DISTRIBUTION; DIFFERENTIAL DIAGNOSIS; LIVER TUMOR; NODULAR HYPERPLASIA; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC;

CONTRAST MEDIUM; DEXTRAN; MAGNETITE NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE;

AREA UNDER CURVE; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; DEXTRANS; DIAGNOSIS, DIFFERENTIAL; FOCAL NODULAR HYPERPLASIA; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; ROC CURVE;

EID: 84927633422     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i14.4334     Document Type: Article

References (25)

1. Lau WY, Lai EC. Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int 2008; 7: 237-257 [PMID: 18522878]
2. Kim MJ, Choi JY, Chung YE, Choi SY. Magnetic resonance imaging of hepatocellular carcinoma using contrast media. Oncology 2008; 75 Suppl 1: 72-82 [PMID: 19092275 DOI: 10.1159/000173427]
3. Goshima S, Kanematsu M, Kondo H, Shiratori Y, Onozuka M, Moriyama N, Bae KT. Optimal acquisition delay for dynamic contrast-enhanced MRI of hypervascular hepatocellular carcinoma. AJR Am J Roentgenol 2009; 192: 686-692 [PMID: 19234264 DOI: 10.2214/AJR.08.1255]
4. Teerasamit W, Saiviroonporn P, Pongpaibul A, Korpraphong P. Benefit of double contrast MRI in diagnosis of hepatocellular carcinoma in patients with chronic liver diseases. J Med Assoc Thai 2014; 97: 540-547 [PMID: 25065095]
5. Maurea S, Mainenti PP, Tambasco A, Imbriaco M, Mollica C, Laccetti E, Camera L, Liuzzi R, Salvatore M. Diagnostic accuracy of MR imaging to identify and characterize focal liver lesions: comparison between gadolinium and superparamagnetic iron oxide contrast media. Quant Imaging Med Surg 2014; 4: 181-189 [PMID: 24914419 DOI: 10.3978/j.issn.2223-4292.2014.01.02]
6. Muhi A, Ichikawa T, Motosugi U, Sou H, Nakajima H, Sano K, Sano M, Kato S, Kitamura T, Fatima Z, Fukushima K, Iino H, Mori Y, Fujii H, Araki T. Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acidenhanced MRI. J Magn Reson Imaging 2011; 34: 326-335 [PMID: 21780227 DOI: 10.1002/jmri.22613]
7. Macarini L, Milillo P, Casavilla A, Scalzo G, Stoppino L, Vinci R, Moretti G, Ettorre G. MR characterization of dysplastic nodules and hepatocarcinoma in the cirrhotic liver with hepatospecific superparamagnetic contrast agents: pathological correlation in explanted livers. Radiol Med 2009; 114: 1267-1282 [DOI: 10.1007/s11547-009-0464-9]
8. Yoo HJ, Lee JM, Lee JY, Kim SH, Kim SJ, Han JK, Choi BI. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver. Invest Radiol 2009; 44: 800-807 [PMID: 19838119 DOI: 10.1097/RLI.0b013e3181bc271d]
9. Kobayashi S, Matsui O, Kamura T, Yamamoto S, Yoneda N, Gabata T, Terayama N, Sanada J. Imaging of benign hypervascular hepatocellular nodules in alcoholic liver cirrhosis: differentiation from hypervascular hepatocellular carcinoma. J Comput Assist Tomogr 2007: 557-563 [PMID: 17882031 DOI: 10.1097/RCT.0b013e3180305bfb]
10. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003; 3: 25 [PMID: 14606960 DOI: 10.1186/1471-2288-3-25]
11. Zheng WW, Zhou KR, Chen ZW, Shen JZ, Chen CZ, Zhang SJ. Characterization of focal hepatic lesions with SPIO-enhanced MRI. World J Gastroenterol 2002; 8: 82-86 [PMID: 11833077]
12. Harisinghani MG, Saini S, Weissleder R, Halpern EF, SchimaW, RubinDL, StillmanAE, SicaGT, SmallWC, HahnPF. Differentiation of liver hemangiomas from metastases and hepatocellular carcinoma at MR imaging enhanced with blood-pool contrast agent code-7227. Radiology 1997; 202: 687-691 [DOI: 10.1148/radiology.202.3.9051017]
13. Liver Cancer Study Group of Japan. Classification of primary liver cancer. Tokyo, Japan: Kanehara & Co, 1997
14. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995; 22: 983-993 [PMID: 7657307 DOI: 10.1002/hep.1840220341]
15. Lim JH, Choi D, Cho SK, Kim SH, Lee WJ, Lim HK, Park CK, Paik SW, Kim YI. Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number. Radiology 2001; 220: 669-676 [PMID: 11526265 DOI: 10.1148/radiol.2203001777]
16. Yoon MA, Kim SH, Park HS, Lee DH, Lee JY, Han JK, Choi BI. Value of dual contrast liver MRI at 3.0T in differentiating welldifferentiated hepatocellular carcinomas from dysplastic nodules: preliminary results of multivariate analysis. Invest Radiol 2009; 44: 641-649 [DOI: 10.1097/RLI.0b013e3181ab6e57]
17. Paley MR, Mergo PJ, Torres GM, Ros PR. Characterization of focal hepatic lesions with ferumoxides-enhanced T2-weighted MR imaging. AJR Am J Roentgenol 2000; 175: 159-163 [PMID: 10882267 DOI: 10.2214/ajr.175.1.1750159]
18. Park HS, Lee JM, Kim SH, Chang S, Kim SJ, Han JK, Choi BI. Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIOenhanced MR imaging at 3.0 Tesla. J Magn Reson Imaging 2009; 29: 328-335 [PMID: 19161184 DOI: 10.1002/jmri.21615]
19. Imai Y, Murakami T, Yoshida S, Nishikawa M, Ohsawa M, Tokunaga K, Murata M, Shibata K, Zushi S, Kurokawa M, Yonezawa T, Kawata S, Takamura M, Nagano H, Sakon M, Monden M, Wakasa K, Nakamura H. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology 2000; 32: 205-212 [PMID: 10915725 DOI: 10.1053/jhep.2000.9113]
20. Zhang XH, Liang BL, Huang SQ. [Correlation between SPIOenhanced magnetic resonance imaging (MRI) and histological grading in hepatocellular carcinoma]. Ai Zheng 2003; 22: 734-738 [PMID: 12866966]
21. Suzuki S, Iijima H, Moriyasu F, Sasaki S, Yanagisawa K, Miyahara T, Oguma K, Yoshida M, Horibe T, Ito N, Kakizaki D, Abe K, Tsuchiya K. Differential diagnosis of hepatic nodules using delayed parenchymal phase imaging of levovist contrast ultrasound: comparative study with SPIO-MRI. Hepatol Res 2004; 29: 122-126 [PMID: 15163434 DOI: 10.1016/j.hepres.2004.02.010]
22. Kato H, Kanematsu M, Kondo H, Goshima S, Matsuo M, Hoshi H, Moriyama N. Ferumoxide-enhanced MR imaging of hepatocellular carcinoma: correlation with histologic tumor grade and tumor vascularity. J Magn Reson Imaging 2004; 19: 76-81 [PMID: 14696223 DOI: 10.1002/jmri.10425]
23. Okada M, Imai Y, Kim T, Kogita S, Takamura M, Kumano S, Onishi H, Hori M, Fukuda K, Hayashi N, Wakasa K, Sakamoto M, Murakami T. Comparison of enhancement patterns of histologically confirmed hepatocellular carcinoma between gadoxetate-and ferucarbotran-enhanced magnetic resonance imaging. J Magn Reson Imaging 2010; 32: 903-913 [PMID: 20882621 DOI: 10.1002/jmri.22333]
24. Inoue T, Kudo M, Watai R, Pei Z, Kawasaki T, Minami Y, Chung H, Fukunaga T, Awai K, Maenishi O. Differential diagnosis of nodular lesions in cirrhotic liver by post-vascular phase contrast-enhanced US with Levovist: comparison with superparamagnetic iron oxide magnetic resonance images. J Gastroenterol 2005; 40: 1139-1147 [PMID: 16378178 DOI: 10.1007/s00535-005-1712-y]
25. Chou CT, Chen RC, Chen WT, Lii JM. Characterization of hyperintense nodules on T1-weighted liver magnetic resonance imaging: comparison of Ferucarbotran-enhanced MRI with accumulation-phase FS-T1WI and gadolinium-enhanced MRI. J Chin Med Assoc 2011; 74: 62-68 [PMID: 21354082 DOI: 10.1016/j.jcma.2011.01.013]